(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide has been researched along with protectin d1 in 1 studies
Studies ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Trials ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Recent Studies (post-2010) ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide) | Studies (protectin d1) | Trials (protectin d1) | Recent Studies (post-2010) (protectin d1) |
---|---|---|---|---|---|
85 | 0 | 65 | 148 | 1 | 95 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ji, RR; Liu, T; Lü, N; Park, CK; Serhan, CN; Xu, ZZ | 1 |
1 other study(ies) available for (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and protectin d1
Article | Year |
---|---|
Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Acrylamides; Analysis of Variance; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Disease Models, Animal; Docosahexaenoic Acids; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Freund's Adjuvant; Ganglia, Spinal; In Vitro Techniques; Inflammation; Long-Term Potentiation; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pain; Pain Measurement; Patch-Clamp Techniques; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Spinal Cord; TRPV Cation Channels; Tumor Necrosis Factor-alpha | 2011 |